Show simple item record

dc.contributor.authorKataja, V. V.en
dc.contributor.authorPavlidis, Nicholasen
dc.creatorKataja, V. V.en
dc.creatorPavlidis, Nicholasen
dc.date.accessioned2018-06-22T09:53:45Z
dc.date.available2018-06-22T09:53:45Z
dc.date.issued2005
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42001
dc.language.isoengen
dc.sourceAnnals of Oncologyen
dc.subjectArticleen
dc.subjectCisplatinen
dc.subjectDoxorubicinen
dc.subjectHumanen
dc.subjectMethotrexateen
dc.subjectVinblastineen
dc.subjectHumansen
dc.subjectCancer survivalen
dc.subjectFollow upen
dc.subjectNeoplasm stagingen
dc.subjectPriority journalen
dc.subjectAntineoplastic combined chemotherapy protocolsen
dc.subjectGemcitabineen
dc.subjectCancer stagingen
dc.subjectTreatment planningen
dc.subjectCancer mortalityen
dc.subjectEpirubicinen
dc.subjectRisk assessmenten
dc.subjectCancer risken
dc.subjectNeoplasm invasivenessen
dc.subjectLymph node dissectionen
dc.subjectMitomycin cen
dc.subjectCancer incidenceen
dc.subjectDiagnosisen
dc.subjectDifferentialen
dc.subjectBladder biopsyen
dc.subjectCystectomyen
dc.subjectCystoscopyen
dc.subjectCancer invasionen
dc.subjectBcg vaccineen
dc.subjectBladder canceren
dc.subjectTransurethral resectionen
dc.subjectUrinary bladder neoplasmsen
dc.titleESMO minimum clinical recommendations for diagnosis, treatment and follow-up of invasive bladder canceren
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1093/annonc/mdi815
dc.description.volume16
dc.description.issueSUPPL. 1en
dc.description.startingpagei43
dc.description.endingpagei44
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.gnosis.orcid0000-0002-2195-9961


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record